Article
Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
The Prostate - 1 Feb 2012
Shui Irene M, Stark Jennifer R, Penney Kathryn L, Schumacher Fredrick R, Epstein Mara M, Pitt Michael J, Stampfer Meir J, Tamimi Rulla M, Lindstrom Sara, Sesso Howard D, Fall Katja, Ma Jing, Kraft Peter, Giovannucci Edward, Mucci Lorelei A
Abstract excerpt
BACKGROUND: Common genetic variants in the Toll-like receptor 4 (TLR4), which is involved in inflammation and immune response pathways, may be important for prostate cancer. METHODS: In a large nested case-control study of prostate cancer in the Physicians' Health Study (1982-2004), 10 single nucleotide polymorphisms (SNPs) were selected and genotyped to capture common variation within the TLR4 gene as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
